Risk of neural tube defects slightly higher for babies of women on HIV therapy containing dolutegravir

Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.